pI: 6.4324 |
Length (AA): 274 |
MW (Da): 31113 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
NA% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_127630)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G36310 | S-adenosylmethionine-dependent methyltransferase domain-containing protein |
Babesia bovis | BBOV_I002790 | conserved hypothetical protein |
Brugia malayi | Bm1_17050 | hypothetical protein |
Candida albicans | CaO19.13735 | similar to Diptheria toxin resistance protein |
Candida albicans | CaO19.6378 | similar to Diptheria toxin resistance protein |
Caenorhabditis elegans | CELE_C14B1.10 | Protein ALKB-8 |
Cryptosporidium hominis | Chro.70078 | hypothetical protein |
Cryptosporidium parvum | cgd7_630 | Ym1014wp-like, Ymb4 methylase |
Dictyostelium discoideum | DDB_G0292448 | hypothetical protein |
Drosophila melanogaster | Dmel_CG17807 | CG17807 gene product from transcript CG17807-RA |
Echinococcus granulosus | EgrG_001113800 | alkylated dna repair protein alkb 8 |
Entamoeba histolytica | EHI_031630 | hypothetical protein, conserved |
Echinococcus multilocularis | EmuJ_001113800 | alkylated dna repair protein alkb 8 |
Giardia lamblia | GL50803_7416 | Methyltransferase, putative |
Homo sapiens | ENSG00000137760 | alkB, alkylation repair homolog 8 (E. coli) |
Leishmania braziliensis | LbrM.35.2860 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_362780.1 | methyltransferase domain containing protein, putative |
Leishmania infantum | LinJ.36.2780 | hypothetical protein, conserved |
Leishmania major | LmjF.36.2650 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.36.2650 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_09472 | hypothetical protein |
Mus musculus | ENSMUSG00000025899 | alkB, alkylation repair homolog 8 (E. coli) |
Neospora caninum | NCLIV_065060 | hypothetical protein, conserved |
Oryza sativa | 4330741 | Os02g0750500 |
Plasmodium berghei | PBANKA_0512100 | methyltransferase, putative |
Plasmodium falciparum | PF3D7_1028000 | methyltransferase, putative |
Plasmodium knowlesi | PKNH_0612400 | methyltransferase, putative |
Plasmodium vivax | PVX_111320 | hypothetical protein, conserved |
Plasmodium yoelii | PY02953 | hypothetical protein |
Saccharomyces cerevisiae | YML014W | Trm9p |
Schistosoma japonicum | Sjp_0000170 | ko:K10770 alkylated DNA repair protein alkB homolog 8, putative |
Schistosoma mansoni | Smp_124160.1 | hypothetical protein |
Schistosoma mansoni | Smp_124160.2 | hypothetical protein |
Schmidtea mediterranea | mk4.007834.04 | Alkylated DNA repair protein alkB homolog 8 |
Schmidtea mediterranea | mk4.011803.00 | Alkylated DNA repair protein alkB homolog 8 |
Trypanosoma brucei gambiense | Tbg972.10.9260 | hypothetical protein, conserved |
Trypanosoma brucei | Tb11.v5.0775 | methyltransferase domain containing protein, putative |
Trypanosoma congolense | TcIL3000_10_6520 | methyltransferase domain containing protein, putative |
Trypanosoma cruzi | TcCLB.510105.150 | methyltransferase domain containing protein, putative |
Trypanosoma cruzi | TcCLB.509715.140 | methyltransferase domain containing protein, putative |
Toxoplasma gondii | TGME49_248960 | methyltransferase domain-containing protein |
Theileria parva | TP01_0568 | hypothetical protein, conserved |
Trichomonas vaginalis | TVAG_031080 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_123080 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.7560 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.7560 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.7560 this record | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.7560 this record | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
PBANKA_0512100 | Plasmodium berghei | Slow | plasmo |
TGME49_248960 | Toxoplasma gondii | Essentiality uncertain | sidik |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | normal (PATO:0000461) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
1 literature reference was collected for this gene.